| Useful Advices |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Sales Training > The Keys To Improved Performance |
|
Useful Advices - The Keys To Improved Performance
In an age of restructuring, downsizing, reorganizing and a general re-evaluation of purpose, mission, corporate destiny and direction, a c According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product oncern for employee as well as organization productivity is at an all time high. What is employee and organization productivity and what a ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in re the essentials involved in attaining it? This could be a book, folks! I only have 300 words to work with here, so permit me a little l lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. eeway. Productivity is when an individual or organization grows and achieves greater success with the least amount of wasted resources, e here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ffort, and time. This definition takes into consideration a number of issues. 1. Reduced employee turnover. 2. A high level of emp d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro loyee satisfaction and empowerment. 3. Profits that can sustain the organizations continued growth. 4. A share of the market t ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc hat can contribute to continuation of the business enterprise. 5. Effective communication throughout the organization as well as in easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi the marketplace. 6. Well-trained and motivated employees throughout the entire organization. 7. Innovative product developmen nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically t and a sensitivity to what consumers want and need now, as well as what they will want and need in the future. 8. Leadership and vi and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ sion. 9. A management team that is in touch with the reality of the marketplace as well as the internal issues within their own orga ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi nization. 10. A clear established corporate direction that is uniformly communicated throughout the organization. 11. Corporat ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a e accountability at every level. 12. A definition of what success is for that organization. 13. A commitment to the health of dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod the community, whether that community is the state, nation, or the world population. I am often asked by my corporate clients how to impr cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ove sales or management or overall organization productivity. It is never a simple answer, as you can see from the above list. And that is tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen not the complete list of issues that must be considered when you are evaluating productivity. There are several key issues to consider: t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel 1.Employee, customer and market loyalty. 2.Management style. 3.Corporate culture. 4.Communication patterns and systems. ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust r>
5.Corporate direction. 6.Competence levels of employees. 7.Competitive posture. 8.The perception(s) of your organizatio y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products n in the marketplace (vendors, customers, competitors). 9.The attitudes and perceptions of your organization by your employees. . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de 10.Your commitment to employee training and development. A lot to consider? Yes. But, if you want a productive organization and not just elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip pay lip service to productivity, I suggest you spend some thinking time about these as well as other issues that impact your organization tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:How to Make Trade Show Displays Need More Business? Create a Co-Op!
|